alexa Trine Hjornevik | Oslo University Hospital
ISSN: 2155-9619

Journal of Nuclear Medicine & Radiation Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Trine Hjornevik

 Trine Hjørnevik
The Intervention Centre
Oslo University Hospital
Biography

 Trine Hjornevik is from The Intervention Centre, Oslo University Hospital, Oslo, Norway.Research interest include  Neuroblastoma; Radionuclide therapy; Nuclear medicine; Nuclear medicine therapy; Radiation safety; Dosimetry

Research Interest

 Neuroblastoma; Radionuclide therapy; Nuclear medicine; Nuclear medicine therapy; Radiation safety; Dosimetry

Publications

Experiences from Introducing Standardized High Dose 131I-mIBG Treatment of Children with Refractory Neuroblastoma: Differences in Effective Dose to Patients and Exposure to Caregivers

Trine Hjornevik, Anne Catrine Martinsen, Signe Elise Hagve, Merethe Wigen Andersen, Ann Cecilie Mørk, Jan Gunnar Fjeld and Ellen Ruud

Research Article: J Nucl Med Radiat Ther 2015, 6: 258

DOI: 10.4172/2155-9619.1000258

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords